Mary Wilson
Well-known member
Published: 06 March 2021
Aditya Moorthy, Rohith Gaikwad, Shreya Krishna, Raghuraj Hegde, K. K. Tripathi, Preeti G. Kale, P. Subramanya Rao, Deepak Haldipur & Krishnamurthy Bonanthaya
DOI: https://doi.org/10.1007/s12663-021-01532-1
Abstract
Objectives
Collate and analyse data of maxillofacial/rhino-cerebro-orbital fungal infections reported during the era of the Covid-19 pandemic, with the aim of investigating the common contributing factors leading to such infections and of highlighting the significance of this surge seen in patients infected with SARS-CoV-2.
Method
This retrospective observational multi-centric study analysed patient data collected from clinicians belonging to different specialties in Bangalore, India. The data included the presentation and management of patients presenting with aggressive maxillofacial and rhino-cerebro-orbital fungal infections and explored the relationship between SARS-CoV-2, corticosteroid administration and uncontrolled diabetes mellitus.
Results
All 18 patients were Covid positive. Sixteen of the 18 patients received steroids for Covid treatment and 16 patients were diabetic (of whom 15 patients who were diabetics received steroids for Covid-19 treatment). Loss of vision was noted in 12 of the 18 patients and 7 of them underwent orbital exenteration. The fungi noted was mucormycosis in 16 patients, aspergillosis in 1 patient and a mixed fungal infection in 1 patient. Eleven of the patients survived, 6 died and 1 was lost to follow-up. There was a significantly higher incidence of diabetes (p?=?0.03) amongst these cohort of patients who were Covid-19 positive with mucormycosis. A significantly higher number (p?=?0.0013) of patients were administered steroids at some point during the treatment.
Conclusion
Despite the limited sample size, it is evident that there is a significant increase in the incidence of angioinvasive maxillofacial fungal infections in diabetic patients treated for SARS-CoV-2 with a strong association with corticosteroid administration.
https://link.springer.com/article/10.1007/s12663-021-01532-1
Aditya Moorthy, Rohith Gaikwad, Shreya Krishna, Raghuraj Hegde, K. K. Tripathi, Preeti G. Kale, P. Subramanya Rao, Deepak Haldipur & Krishnamurthy Bonanthaya
DOI: https://doi.org/10.1007/s12663-021-01532-1
Abstract
Objectives
Collate and analyse data of maxillofacial/rhino-cerebro-orbital fungal infections reported during the era of the Covid-19 pandemic, with the aim of investigating the common contributing factors leading to such infections and of highlighting the significance of this surge seen in patients infected with SARS-CoV-2.
Method
This retrospective observational multi-centric study analysed patient data collected from clinicians belonging to different specialties in Bangalore, India. The data included the presentation and management of patients presenting with aggressive maxillofacial and rhino-cerebro-orbital fungal infections and explored the relationship between SARS-CoV-2, corticosteroid administration and uncontrolled diabetes mellitus.
Results
All 18 patients were Covid positive. Sixteen of the 18 patients received steroids for Covid treatment and 16 patients were diabetic (of whom 15 patients who were diabetics received steroids for Covid-19 treatment). Loss of vision was noted in 12 of the 18 patients and 7 of them underwent orbital exenteration. The fungi noted was mucormycosis in 16 patients, aspergillosis in 1 patient and a mixed fungal infection in 1 patient. Eleven of the patients survived, 6 died and 1 was lost to follow-up. There was a significantly higher incidence of diabetes (p?=?0.03) amongst these cohort of patients who were Covid-19 positive with mucormycosis. A significantly higher number (p?=?0.0013) of patients were administered steroids at some point during the treatment.
Conclusion
Despite the limited sample size, it is evident that there is a significant increase in the incidence of angioinvasive maxillofacial fungal infections in diabetic patients treated for SARS-CoV-2 with a strong association with corticosteroid administration.
https://link.springer.com/article/10.1007/s12663-021-01532-1